We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Sign up to read this article for FREE!

After signing up, you'll start to receive regular news updates from us.

Research in the News: Arming the Immune System to Fight Myeloma

News  
Published: March 5, 2013 
Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above. ✖

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

By submitting your email address, you agree to receive email communications related to Technology Networks content, products, or our partners. You may unsubscribe from these communications at any time as we respect your privacy. View our Privacy Policy for more information.
Read time: Less than a minute

Yale researchers led by Madhav Dhodapkar, professor of hematology and immunobiology at Yale School of Medicine, showed how combining drugs that regulate the natural killer cells of the immune system with dendritic cells loaded with anti-tumor drugs may prevent the asymptomatic precursor state of multiple myeloma from progressing to a full blown case of the disease.

Related Topic Pages
The Immune System
Advertisement
Advertisement
Advertisement
Decoratvive background images
Never miss a story
with the Breaking Science News daily newsletter